References
- Wang B, Chen M-Z. Effects of indomethacin on secretory function of synoviocytes from adjuvant arthritis rats. Int J Tissue React 1998;20:91–4.
- Zernicke FtF, Wohl GR, Greenwald RA, Moak SA, Leng W, Golub LM. Administration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthri-tis. J Ftheumatol 1997;24:1324–31.
- Smith-Oliver T, Noel LS, Stimpson SS, Yarnall DP, Connolly KM. Elevated levels of TNF in the joints of adjuvant arthritic rats. Cytokines 1993;5:298–304.
- Yamamoto N, Sakai F, Yamazaki H, Nakahara K, Okuhara M. Effect of FR167653, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation. Eur J Pharmacol 1996;314: 137–42.
- Yamamoto N, Sakai F, Yamazaki H, Sato N, Nakahara K, Okuhara M. FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor-a, ameliorates endotoxin-induced shock. Eur J Pharmacol 1997;327:169–75.
- Cannon GW, Woods ML, Clayton F, Griffiths MM. Induction of arthritis in DA rats by incomplete Freund's adjuvant. J Ftheumatol 1993;20:7–11.
- Clark RL, Cuttino JT, Anderle SK, Cromartie WJ, Schwab JH. Radiologic analysis of arthritis in rats after systemic injection of streptococcal cell walls. Arthritis Rheum 1979;22:25–35.
- Roubenoff R, Freeman LM, Smith DE, Abad LW, Dinarello CA, Kehayias JJ. Adjuvant arthritis as a model of inflammatory cachexia. Arthritis Rheum 1997;40:534–9.
- Kaibara N, Hotokebuchi T, Takagishi K, Katsuki I, Morinaga M, Arita C, et al. Pathogenetic difference between collagen arthritis and adjuvant arthritis. J Exp Med 1984;159:1388–96.
- Kawai S, Nagai K, Nishida S, Sakyo K, Murai E, Mizushima Y. Low-dose pulse methotrexate inhibits articular destruction of adju-vant arthritis in rats. J Pharm Pharmacol 1997;49:213–5.
- Conway JG, Wakefield JA, Brown RH, Marron BE, Sekut L, Stimpson SA, et al. Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor. J Exp Med 1995;182:449–57.